Suppr超能文献

对2019冠状病毒病对肺癌患者影响的恐惧与认知:一项单机构调查

Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey.

作者信息

Catania Chiara, Spitaleri Gianluca, Del Signore Ester, Attili Ilaria, Radice Davide, Stati Valeria, Gianoncelli Letizia, Morganti Stefania, de Marinis Filippo

机构信息

Division of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, Milan, Italy.

出版信息

Front Oncol. 2020 Oct 14;10:584612. doi: 10.3389/fonc.2020.584612. eCollection 2020.

Abstract

In February 2020, Italy became one of the first countries to be plagued by the SARS-CoV-2 pandemic, COVID-19. In March 2020, the Italian government decreed a lockdown for the whole country, which overturned communication systems, hospital organization, and access to patients and their relatives and carers. This issue had a particular regard for cancer patients. Our Thoracic Oncology Division therefore reorganized patient access in order to reduce the risk of contagion and, at the same time, encourage the continuation of treatment. Our staff contacted all patients to inform them of any changes in treatment planning, check that they were taking safety measures, and ascertain their feelings and whether they had any COVID-19 symptoms. To better understand patients' fears and expectations of during the pandemic period, we created a nine-question interview, administered from April to May 2020 to 156 patients with lung cancer. Patients were classified by age, sex, comorbidity, disease stage, prior treatment, and treatment type. The survey showed that during the pandemic period some patients experienced fear of COVID-19, in particular: women (55% vs. 33%), patients with comorbidities (24% vs. 9%), and patients who had already received prior insult (radiotherapy or surgery) on the lung (30% vs. 11%). In addition, the patients who received oral treatment at home or for whom intravenous treatment was delayed, experienced a sense of relief (90% and 72% respectively). However, only 21% of the patients were more afraid of COVID-19 than of their cancer, in particular patients with long-term (> 12 months) vs. short-term cancer diagnosis (28% vs. 12.5%, respectively). Furthermore, the quarantine period or even just the lockdown period alone, worsened the quality of life of some patients (40%), especially those in oral treatment (47%). Our data demonstrate how lung cancer patients are more afraid of their disease than of a world pandemic. Also this interview indirectly highlights the clinician's major guiding principle in correctly and appropriately managing not just the patient's expectations of their illness and its treatment, but also and especially of the patient's fears.

摘要

2020年2月,意大利成为首批受严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行——新型冠状病毒肺炎(COVID-19)困扰的国家之一。2020年3月,意大利政府颁布全国封锁令,这颠覆了通信系统、医院组织以及接触患者及其亲属和护理人员的方式。这个问题对癌症患者尤为重要。因此,我们的胸科肿瘤学部门重新安排了患者就诊流程,以降低传染风险,同时鼓励继续治疗。我们的工作人员联系了所有患者,告知他们治疗计划的任何变化,检查他们是否采取了安全措施,并了解他们的感受以及是否有任何COVID-19症状。为了更好地了解患者在大流行期间的恐惧和期望,我们设计了一份包含九个问题的访谈问卷,于2020年4月至5月对156名肺癌患者进行了调查。患者按年龄、性别、合并症、疾病阶段、既往治疗情况和治疗类型进行分类。调查显示,在大流行期间,一些患者对COVID-19感到恐惧,特别是:女性(55%对33%)、有合并症的患者(24%对9%)以及肺部已接受过先前损伤(放疗或手术)的患者(30%对11%)。此外,在家接受口服治疗或静脉治疗延迟的患者感到如释重负(分别为90%和72%)。然而,只有21%的患者更害怕COVID-19而非癌症,特别是长期(>12个月)与短期癌症诊断的患者(分别为28%对12.5%)。此外,隔离期甚至仅仅是封锁期本身,都使一些患者的生活质量下降(40%),尤其是接受口服治疗的患者(47%)。我们的数据表明肺癌患者更害怕自己的疾病而非全球大流行。这次访谈还间接凸显了临床医生的主要指导原则,即不仅要正确且适当地管理患者对疾病及其治疗的期望,更要尤其关注患者的恐惧。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a26/7591454/8695aa5d3f73/fonc-10-584612-g001.jpg

相似文献

1
Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey.
Front Oncol. 2020 Oct 14;10:584612. doi: 10.3389/fonc.2020.584612. eCollection 2020.
4
Emergency surgery in COVID-19 outbreak: Has anything changed? Single center experience.
World J Clin Cases. 2020 Sep 6;8(17):3691-3696. doi: 10.12998/wjcc.v8.i17.3691.
5
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients.
Transl Oncol. 2022 Aug;22:101457. doi: 10.1016/j.tranon.2022.101457. Epub 2022 May 19.
6
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model.
Front Oncol. 2020 Apr 22;10:665. doi: 10.3389/fonc.2020.00665. eCollection 2020.
7
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients.
Front Neurol. 2020 May 29;11:564. doi: 10.3389/fneur.2020.00564. eCollection 2020.
8
The Impact of the COVID-19 Pandemic on Cancer Patient's Management-Lithuanian Cancer Center Experience.
Healthcare (Basel). 2021 Nov 9;9(11):1522. doi: 10.3390/healthcare9111522.
9
Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic.
Int J Clin Oncol. 2021 Aug;26(8):1569-1574. doi: 10.1007/s10147-021-01971-3. Epub 2021 Jun 18.
10
Impact of the COVID-19 Pandemic on Patients and Staff in Radiation Oncology Departments in Belgium: A National Survey.
Front Oncol. 2021 Mar 19;11:654086. doi: 10.3389/fonc.2021.654086. eCollection 2021.

引用本文的文献

1
The burden of COVID-19 death for different cancer types: a large population-based study.
J Glob Health. 2025 Feb 14;15:04046. doi: 10.7189/jogh.15.04046.
2
Chemotherapy delays among cancer patients in Iran during COVID-19 pandemic.
BMC Public Health. 2024 Aug 23;24(1):2299. doi: 10.1186/s12889-024-19780-4.
6
The Influence of COVID-19 on New Lung Cancer Diagnoses, by Stage and Treatment, in Northern Italy.
Biology (Basel). 2023 Feb 28;12(3):390. doi: 10.3390/biology12030390.
7
Integration of art and technology in personalized radiation oncology care: Experiences, evidence, and perspectives.
Front Public Health. 2023 Jan 23;11:1056307. doi: 10.3389/fpubh.2023.1056307. eCollection 2023.
8
Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis.
Transl Oncol. 2023 Feb;28:101605. doi: 10.1016/j.tranon.2022.101605. Epub 2022 Dec 19.
9
10

本文引用的文献

1
Cancer Patients and Risk of Mortality for COVID-19.
Cancer Cell. 2020 Aug 10;38(2):161-163. doi: 10.1016/j.ccell.2020.07.006. Epub 2020 Jul 25.
2
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.
ESMO Open. 2020 Jun;5(Suppl 3). doi: 10.1136/esmoopen-2020-000820.
4
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol. 2020 Jul;21(7):914-922. doi: 10.1016/S1470-2045(20)30314-4. Epub 2020 Jun 12.
5
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9. Epub 2020 May 28.
6
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic.
J Thorac Oncol. 2020 Jul;15(7):1119-1136. doi: 10.1016/j.jtho.2020.05.001. Epub 2020 May 15.
7
Severe Covid-19.
N Engl J Med. 2020 Dec 17;383(25):2451-2460. doi: 10.1056/NEJMcp2009575. Epub 2020 May 15.
8
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model.
Front Oncol. 2020 Apr 22;10:665. doi: 10.3389/fonc.2020.00665. eCollection 2020.
9
Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City.
Ann Oncol. 2020 Aug;31(8):1088-1089. doi: 10.1016/j.annonc.2020.04.006. Epub 2020 Apr 21.
10
Testing for COVID-19 in lung cancer patients.
Ann Oncol. 2020 Jul;31(7):832-834. doi: 10.1016/j.annonc.2020.04.002. Epub 2020 Apr 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验